Applied Therapeutics, Inc.
Pharmaceutical Preparations · NEW YORK · NY
High confidence (85%)
Updated Oct 10, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: Applied Therapeutics, Inc. deregistered its securities (Feb 13, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Applied Therapeutics, Inc. deregistered its securities
Feb 13, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 d70674d1512g.htm 15-12G 15-12G As filed with the Securities and Exchange Commission on February 13, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-38898 Applied Therapeutics, Inc. (Exact name of registrant as specified in its charter) 545 Fifth Avenue, Suite 1400 New York, NY 10017 (Address, including z…”
Applied Therapeutics, Inc. was delisted from its exchange
Feb 3, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001697532 Applied Therapeutics, Inc. 001-38898 340 Madison Avenue New York NY NEW YORK 10173 2122209226 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta Director 2026-02-03”
Applied Therapeutics, Inc. received a delisting notice from its exchange
Feb 3, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 of this Current Report on Form 8-K are incorporated herein by reference into this Item 2.01. On February 3, 2026, Purchaser irrevocably accepted for payment all Shares validly tendered pursuant to the Offer and not validly withdrawn as of the expiration of the Offer. On February 3, 2026, the Merger was completed pursuant to Section 251(h) of the DGCL, with no vote of the stockholders of the Company required to consummate the Merger. Upon the consummation of the Merger, the Company became an indirect wholly owned subsidiary of Parent. The aggregate consideration paid by Purchaser in t…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- SEC CIK
- 0001697532
- Website
- —
- —
- Headquarters
- NEW YORK, NY
- Also known as
- Applied Therapeutics Inc.
- Legal entities
- Applied Therapeutics, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Applied Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — NEW YORK, NY
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 d70674d1512g.htm 15-12G 15-12G As filed with the Securities and Exchange Commission on February 13, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-38898 Applied Therapeutics, Inc. (Exact name of registrant as specified in its charter) 545 Fifth Avenue, Suite 1400 New York, NY 10017 (Address, including z…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001697532 Applied Therapeutics, Inc. 001-38898 340 Madison Avenue New York NY NEW YORK 10173 2122209226 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta Director 2026-02-03
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 of this Current Report on Form 8-K are incorporated herein by reference into this Item 2.01. On February 3, 2026, Purchaser irrevocably accepted for payment all Shares validly tendered pursuant to the Offer and not validly withdrawn as of the expiration of the Offer. On February 3, 2026, the Merger was completed pursuant to Section 251(h) of the DGCL, with no vote of the stockholders of the Company required to consummate the Merger. Upon the consummation of the Merger, the Company became an indirect wholly owned subsidiary of Parent. The aggregate consideration paid by Purchaser in t…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:29 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:09 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.